Carmel-based life and health insurer CNO Financial Group Inc. said Tuesday that its third-quarter earnings jumped nearly four times over last year's third-quarter results, but mostly because of a one-time tax-related gain.
Federal health officials on Monday approved the first generic versions of the blockbuster drug Zyprexa, which posted sales of $5.7 billion last year for Indianapolis-based drugmaker Eli Lilly and Co Inc.
Lilly’s patent-loss challenges—the biggest of which takes effect today—will force the company to rely even more on its 1,300 Indiana vendors.
Cigna Corp. will buy fellow health insurer HealthSpring Inc. in a $3.8 billion deal as it becomes the latest managed care company to snap up a bigger share of the fast-growing Medicare Advantage market.
As constitutional challenges to the health reform law’s mandate to buy insurance advance, WellPoint Inc.’s chief financial officer reiterated that the company does not object to the mandate, just to its lack of penalties.
The hospitals owned by Boone and Hamilton counties are following the lead of Indianapolis-based Wishard Health Services and its parent organization by acquiring far-flung nursing homes, hoping the strategy proves as lucrative.
BioCrossroads’ Indiana Seed Fund has invested $300,000 in a startup company chaired by a former Eli Lilly and Co. executive developing an absorbable stent.
The Indianapolis-based drugmaker earned $1.24 billion in the three months ended Sept. 30, down 5 percent from the same quarter a year ago, even as revenue surged 9 percent.
Eli Lilly and Co. and Amylin Pharmaceuticals Inc.’s Byetta has received expanded approval for use with the world’s top-selling insulin to treat Type 2 diabetes.
Indiana officials contend the state's Planned Parenthood chapter could end a fierce legal dispute over abortion funding by simply separating its abortion business from other services.
CBRE Inc. accuses the local hospital system of cheating it out of consulting fees that could top seven figures related to several building projects.
Kexue Huang faces up to 13 years in prison after pleading guilty Tuesday morning to sending trade secrets worth millions to China and Germany.
The Indiana Court of Appeals reversed a Marion Superior Court decision to dismiss a lawsuit by two uninsured patients who received care at IU Health North Hospital in Carmel.
Medicare supplement policies are reportedly one of the targets of Congress’ special deficit-reduction committee—and that’s not good news for Carmel-based CNO Financial Group Inc.
An IU official said premiums continue to rise and the university can't continue matching the amount of the increase.
The device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery of the upper leg.
The company saw sales surge after introducing software in May that helps medical labs manage their disparate computer systems from a Web portal.
Peripheral vascular devices, including stents, angioplasty balloons and synthetic grafts, generated $4.3 billion in global revenue last year and may earn $5.6 billion in 2014.
Bryce Carmine, president of Lilly’s bio-medicines division, and Frank Deane, president of Lilly’s global manufacturing operations, both will retire on Dec. 31.
